Gene transfer for cerebrovascular disease

Current Cardiology Reports

Volumn 3, Issue 1, 2001, Pages 10-16

  Khurana, Vini G ^a   Katusic, Zvonimir S ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS; ANIMAL; CEREBROVASCULAR DISEASE; GENE THERAPY; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN; REVIEW;

ADENOVIRIDAE; ANIMALS; CEREBROVASCULAR DISORDERS; GENE THERAPY; GENETIC VECTORS; HUMANS; TRANSDUCTION, GENETIC;

EID: 0035234518     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-001-0004-2     Document Type: Article

References (46)

1. Rosenberg SA, Aebersold P, Cornetta K, et al.: Gene transfer into humans: immunotherapy of patients with advanced melanoma using tumor infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med 1990, 323:570-578.
2. Brenner M: Reports of adenovector "death" are greatly exaggerated. Mol Ther 2000, 1:205.
3. Blau HM, Springer ML: Gene therapy - a novel form of drug delivery: N Engl J Med 1995, 333:1204-1207.
4. Chen AFY, O'Brien T, Katusic ZS: Transfer and expression of recombinant nitric oxide synthase genes in the cardiovascular system. Trends Pharmacol Sci 1998, 19:276-286.
5. O'Brien T: Gene transfer and vascular disease. Journal of the Irish Colleges of Physicians and Surgeons 1998, 27:33-39.
6. Onoue H, Tsutsui M, Smith L, et al.: Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery after experimental subarachnoid hemorrhage. Stroke 1998, 29:1959-1966.
7. Rekhter MD, Simari RD, Work CW, et al.: Gene transfer into normal and atherosclerotic human blood vessels. Circ Res 1998, 82:1243-1252.
8. Russell SJ: Science, medicine, and the future: gene therapy: BMJ 1997, 315:1289-1292.
9. Dyer MR, Herrling PL: Progress and potential for gene-based medicines. Mol Ther 2000, 1:213-224.
10. Carter BJ: Gene therapy as drug development. Mol Ther 2000, 1:211-212.
11. Heistad DD, Faraci FM: Gene therapy for cerebral vascular disease. Stroke 1996, 27:1688-1693.
12. Richter M, Iwata A, Nyhuis J, et al.: Adeno-associated virus vector transduction of vascular smooth muscle cells in vivo. Physiol Genom 2000, 2:117-127.
13. Ono S, Date I, Onoda K, et al.: Decoy administration of NF-kB into the subarachnoid space for cerebral angiopathy. Human Gene Ther 1998, 9:1003-1011.
14. Von der Leyen HE, Gibbons GH, Morishita R, et al.: Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A 1995, 92:1137-1141.
15. Newman KD, Dunn PF, Owens JW, et al.: Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest 1995, 96:2955-2965.
16. Thomas CE, Schiedner G, Kochanek S, et al.: Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with firstgeneration, but not with high-capacity, adenovirus vectors: toward realistic long-term neurological gene therapy for chronic disease. Proc Natl Acad Sci U S A 2000, 97:7482-7487.
17. Vassalli G, Agah R, Qiao R, et al.: A mouse model of arterial gene transfer: antigen-specific immunity is a minor determinant of the early loss of adenovirus-mediated transgene expression. Circ Res (Online) 1999, 85:e25-e32.
18. Wen S, Schneider DB, Driscoll RM, et al.: Second-generation adenoviral vectors do not prevent rapid loss of transgene expression and vector DNA from the arterial wall. Arterioscler Thromb Vasc Biol 2000, 20:1452-1458.
19. Wood MJA, Charlton HM, Wood KJ, et al.: Immune responses to adenovirus vectors in the nervous system. Trends Neurosci 1996, 19:497-501.
20. Chen AFY, O'Brien T, Tsutsui M, et al.: Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery. Circ Res 1997A, 80:327-335.
21. Spector DJ, Samaniego LA: Construction and isolation of recombinant adenovirus with gene replacements. In Viral Gene Techniques: Methods in Molecular Genetics vol 7. Edited by Cole KW. San Diego: Academic Press; 1995:31-44.
22. Bergelson JM, Cunningham JA, Droguett G, et al.: Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997, 275:1320-1323.
23. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR: Integrins avb3 and avb5 promote adenovirus internalization but not virus attachment. Cell 1993, 73:309-319.
24. Channon KM, Blazing MA, Shetty GA, et al.: Adenoviral gene transfer of nitric oxide synthase: high level expression in human vascular cells. Cardiovasc Res 1996, 32:962-972.
25. Hobbs AJ, Higgs A, Moncada S: Inhibition of nitric oxide synthase as a potential therapeutic target. Ann Rev Pharmacol Toxicol 1999, 39:191-220.
26. Khurana VG, Besser M: Pathophysiological basis of cerebral vasospasm following aneurysmal subarachnoid haemorrhage. J Clin Neurosci 1997, 4:122-131.
27. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991, 43:109-142.
28. Thomas JE, Rosenwasser RH, Armondo RA, et al.: Safety of intrathecal sodium nitroprusside for the treatment and prevention of refractory cerebral vasospasm and ischemia in humans. Stroke 1999, 30:1409-1416.
29. Vanhoutte PM: Endothelial dysfunction and inhibition of converting enzyme. Eur Heart J 1998, 19:J7-J15.
30. Vanhoutte PM: How to assess endothelial function in human blood vessels. J Hypertension 1999, 17:1047-1058.
31. Onoue H, Tsutsui M, Smith L, O'Brien T, Katusic ZS: Adventitial expression of recombinant endothelial nitric oxide synthase gene reverses vasoconstrictor effect of endothelin-1. J Cerebr Blood Flow Metab 1999, 19:1029-1037.
32. Suzuki H, Kanamaru K, Tsunoda H, et al.: Heme oxygenase-1 gene induction as an intrinsic regulation against delayed cerebral vasospasm in rats. J Clin Invest 1999, 104:59-66.
33. Toyoda K, Faraci FM, Russo AF, et al.: Gene transfer of calcitonin gene-related peptide to cerebral arteries. Am J Physiol 2000A, 278:H586-H594.
34. Khurana VG, Smith LA, Weiler DA, et al.: Adenovirus-mediated gene transfer to human cerebral arteries. J Cerebr Blood Flow Metab 2000, 20:1360-1371.
35. Kullo IJ, Mozes G, Schwartz RS, et al.: Enhanced endotheliumdependent relaxations after gene transfer of recombinant endothelial nitric oxide synthase to rabbit carotid arteries. Hypertension 1997, 30:314-320.
36. Ooboshi H, Chu Y, Rios CD, et al.: Altered vascular function after adenovirus-mediated overexpression of endothelial nitric oxide synthase. Am J Physiol 1997, 273:H265-H270.
37. Tsutsui M, Onoue H, Iida Y, et al.: Effects of recombinant eNOS gene expression on reactivity of small cerebral arteries. Am J Physiol 2000B, 278:H420-H427.
38. Chen AFY, Jiang SW, Crotty TB, et al.: Effects of in vivo adventitial expression of recombinant endothelial nitric oxide synthase gene in cerebral arteries. Proc Natl Acad Sci U S A 1997B, 94:12568-12573.
39. Christenson SD, Lake KD, Ooboshi H, et al.: Adenovirusmediated gene transfer in vivo to cerebral blood vessels and perivascular tissue in mice. Stroke 1998, 29:1411-1416.
40. Ooboshi H, Welsh MJ, Rios CD, et al.: Adenovirus-mediated gene transfer in vivo to cerebral blood vessels and perivascular tissue. Circ Res 1995, 77:7-13.
41. Stoodley M, Weihl CC, Zhang ZD, et al.: Effect of adenovirusmediated nitric oxide synthase gene transfer on vasospasm after experimental subarachnoid hemorrhage. Neurosurgery 2000, 45:1193-1203.
42. Toyoda K, Andresen JJ, Zabner J, et al.: Calcium phosphate precipitates augment adenovirus-mediated gene transfer to blood vessels in vitro and in vivo. Gene Ther 2000B, 7:1284-1291.
43. Tsutsui M, Chen AFY, O'Brien T, et al.: Adventitial expression of recombinant eNOS gene restores NO production in arteries without endothelium. Arterioscler Thromb Vasc Biol 1998, 18:1231-1241.
44. Tsutsui M, Onoue H, Iida Y, et al.: B1 and B2 bradykinin receptors on adventitial fibroblasts of cerebral arteries are coupled to recombinant eNOS. Amer J Physiol 2000A, 278:H367-H372.
45. Kim S, Lin H, Barr E, et al.: Transcriptional targeting of replication-defective adenovirus transgene expression to smooth muscle cells in vivo. J Clin Invest 1997, 100:1006-1014.
46. Davidson BL, Allen ED, Kozarsky KF, et al.: A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nat Genet 1993, 3:219-223.